Article Details

CHANGES IN THE NATURE OF PHARMACEUTICAL R&D PROGRAMS

Dr. George Patani

Associate Editor

Indian Drugs

https://doi.org/10.53879/id.59.03.p0005


ABSTRACT

Dear Reader,

The global innovation index 2021 ranked INDIA 48th among 131 countries. This low ranking assigned to India reflects the quality of our research programs. In the realm of pharmaceuticals, the Indian industry has excelled in the manufacture of low value generic products, however we are yet to demonstrate our capability to manufacture newer, innovative and advanced products such as biologicals, complex generics and higher value device based drug systems.

Year 2022 | Volume No. 59 | Issue No.3 | Page No. 5-6
Recent Issue
Current Issue
June 2025
Quick Contact